EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Reversal of Congenital Hypogonadotropic Hypogonadism

Andrew A Dwyer iD, Maria Stamou iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf610 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Andrew A Dwyer und 1 weiteren Autor:innen. Beteiligte Einrichtung: William F. Connell School of Nursing, Boston College, Chestnut Hill, MA 02467, USA. Hauptthemen laut MEDLINE: Hypogonadism, Hormone Replacement Therapy. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human, National Institutes of Health Eunice Kennedy Shriver.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Congenital genetic disorders have been traditionally considered to be lifelong. An exception to this long-held view is the reversal of congenital hypogonadotropic hypogonadism (CHH). Approximately 10% of male individuals with CHH undergo reversal with sustained hypothalamic-pituitary-gonadal (HPG) axis activation and/or fertility after discontinuing hormonal treatment. Evidence Acquisition We conducted a structured, systematic literature search to identify relevant articles published on reversal of CHH in males (up to 2025). This mini-review provides a concise overview and synthesizes findings to inform clinical management of CHH. Evidence Synthesis We identified 31 articles reporting reversal of CHH in males, including cases of severe GnRH deficiency and individuals harboring pathogenic variants in CHH genes. Reversal is distinct from delayed puberty, and olfactory phenotype (ie, anosmia) does not predict HPG axis recovery. In males, reversal universally occurs after achieving normal serum testosterone levels on hormone therapy. Testicular growth on testosterone replacement is a hallmark of HPG axis activation—yet reversal is not always lasting. Cases exist on a continuum from normosmic individuals with severe GnRH deficiency to milder cases with partial spontaneous puberty (Pasqualini syndrome subtype). Pathogenic variants in GNRHR favor reversal while ANOS1 variants virtually exclude HPG axis recovery.

Conclusion

The reversal phenomenon in males has expanded our understanding of the regulation of human reproduction—yet precise mechanism(s) have yet to be elucidated. Clinicians can use clinical signs and genetic testing to identify patients who may benefit from close surveillance of reversal. Insights from reversal of CHH reversal have helped shape the first tailored approach managing CHH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypogonadismHormone Replacement TherapyHumansMaleTestosteroneGonadotropin-Releasing HormoneHypothalamo-Hypophyseal SystemNerve Tissue ProteinsExtracellular Matrix Proteins

Stichwörter der Autor:innen

Kallmann syndromegeneticspubertyreproduction

Substanzen

TestosteroneGonadotropin-Releasing HormoneANOS1 protein, humanNerve Tissue ProteinsExtracellular Matrix Proteins

Autor:innen und Institutionen

  • William F. Connell School of Nursing, Boston College, Chestnut Hill, MA 02467, USA.
  • P50 Massachusetts General Hospital-Harvard Center for Reproductive Medicine, Boston, MA 02114, USA.
  • Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.

ORCID-Profile: Andrew A Dwyer, Maria Stamou

Förderung

  • NICHD NIH HHS
  • National Institute of Child Health and Human
  • National Institutes of Health Eunice Kennedy Shriver

Zitieren

APA

Dwyer, A. A., & Stamou, M. (2026). Reversal of Congenital Hypogonadotropic Hypogonadism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf610

Vancouver

Dwyer AA, Stamou M. Reversal of Congenital Hypogonadotropic Hypogonadism. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf610

BibTeX
@article{Dwyer2026,
  author = {Dwyer, Andrew A and Stamou, Maria},
  title = {Reversal of Congenital Hypogonadotropic Hypogonadism},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf610}
}
Kostenlos starten →